Your browser doesn't support javascript.
loading
IL-2 produced by HBV-specific T cells as a biomarker of viral control and predictor of response to PD-1 therapy across clinical phases of chronic hepatitis B.
Chua, Conan; Salimzadeh, Loghman; Ma, Ann T; Adeyi, Oyedele A; Seo, Hobin; Boukhaled, Giselle M; Mehrotra, Aman; Patel, Anjali; Ferrando-Martinez, Sara; Robbins, Scott H; La, Danie; Wong, David; Janssen, Harry L A; Brooks, David G; Feld, Jordan J; Gehring, Adam J.
Afiliação
  • Chua C; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Salimzadeh L; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Ma AT; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Adeyi OA; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Seo H; Liver Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
  • Boukhaled GM; Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
  • Mehrotra A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Patel A; Princess Margaret Cancer Centre, University Health Network, Toronto, Ontario, Canada.
  • Ferrando-Martinez S; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Robbins SH; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • La D; Microbial Sciences, Biopharmaceuticals R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Wong D; Late Stage Oncology Development, Oncology R&D, AstraZeneca, Gaithersburg, Maryland, USA.
  • Janssen HLA; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Brooks DG; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
  • Feld JJ; Institute of Medical Sciences, University of Toronto, Toronto, Ontario, Canada.
  • Gehring AJ; Toronto Centre for Liver Disease, Toronto General Research Institute, University Health Network, Toronto, Ontario, Canada.
Hepatol Commun ; 7(12)2023 Dec 01.
Article em En | MEDLINE | ID: mdl-38055623
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2023 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Contexto em Saúde: 1_ASSA2030 / 2_ODS3 / 4_TD / 6_ODS3_enfermedades_notrasmisibles Base de dados: MEDLINE Assunto principal: Hepatite B Crônica Limite: Humans Idioma: En Revista: Hepatol Commun Ano de publicação: 2023 Tipo de documento: Article